Sangamo Therapeutics France

Address
Les Cardoulines Ht1 Allee De La Nertiere, Sophia Antipolis

Sponsor Overview

assignment
1
sponsored trial
science
1
molecule
location_city
4
research centres
public
2
countries
person_search
2
investigators

Specializations

Renal Transplantation and Graft Rejection

Research activity is centred on prophylaxis against renal transplant rejection, with interest in immune tolerance and protection of transplanted kidneys in living donor renal transplantation.

  • Renal allograft rejection prevention
  • Transplant immunology
  • Kidney transplant recipient care

The sponsor’s clinical focus in this area is aligned with therapies designed to support post-transplant graft survival and reduce immune-mediated injury.

Cell Therapy and Immune Modulation

The trial landscape includes autologous chimeric antigen receptor T regulatory cell therapy, reflecting interest in engineered cellular approaches for controlling transplant-related immune responses.

  • T regulatory cell therapy
  • Autologous cell-based treatment
  • Antigen-specific immune targeting

This area links advanced cellular immunotherapy with transplant-focused applications in organ tolerance.

Safety and Tolerability in Transplant Medicine

Clinical interest also extends to early evaluation of short-term safety and tolerability in renal transplant recipients, supporting the development of treatment options intended for use alongside transplantation care.

  • Post-infusion safety assessment
  • Transplant recipient monitoring
  • Immune-related treatment effects

These themes indicate a therapeutic emphasis on balancing immune control with clinical acceptability in the transplant setting.

Sponsored Trials

Trial Name Country Status
Evaluation of Safety and Tolerability of TX200-TR101 in Prophylaxis Against Renal Transplant Rejection in Living Donor RecipientsBelgium BelgiumThe Netherlands The NetherlandsNot Recruiting

Data & Insights

science
Molecule Portfolio
Compounds under investigation
0
Exclusive Molecules
out of 1 total (0% not shared with other sponsors)

This sponsor works with 1 molecule, of which 0 are not being studied by other sponsors.

hub
Site Partnerships
Collaboration with research centres
0%
Return partnership rate
0 of 4 sites collaborated multiple times

This sponsor has worked with 4 sites across their trial portfolio.

Therapeutic Focus

  • 1.
    Immune System Diseases1 trial
    322 other sponsors

Partnered Research Centres

4 centres
location_city
assignment711
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
Address
Dr. Molewaterplein 40, 3015 GD Rotterdam
Learn morearrow_forward
location_city
assignment1165
Katholieke Universiteit te Leuven
Address
Herestraat 49, 3000 Leuven
Learn morearrow_forward
location_city
assignment494
Universitair Medisch Centrum Groningen
Address
Hanzeplein 1, 9713 GZ Groningen
Learn morearrow_forward
location_city
assignment4
Universiteit Leiden
Address
Rapenburg 70, 2311 EZ Leiden
Learn morearrow_forward

Want to get in touch with this sponsor?

Send a question and we'll pass it on to Sangamo Therapeutics France.

Need a custom report on this sponsor?

Competitive positioning, market entry, partnership opportunities — tell us the question.

Is something out of date?

Tell us what needs correcting and we'll update this profile.